Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations

Ewing's sarcoma family of tumours comprises a group of very aggressive diseases that are potentially curable with multimodality treatment. Despite the undoubted success of current treatment, approximately 30% of patients will relapse and ultimately die of disease. The insulin-like growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Olmos, David, Martins, Ana Sofia, Jones, Robin L., Alam, Salma, Scurr, Michelle, Judson, Ian R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103989/
https://www.ncbi.nlm.nih.gov/pubmed/21647361
http://dx.doi.org/10.1155/2011/402508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103989/
https://www.ncbi.nlm.nih.gov/pubmed/21647361
http://dx.doi.org/10.1155/2011/402508

Ejemplares similares